Skip to content
Live
Trending storyPast story

Huawei does not make medicine, becoming the foundation of AI pharmaceutical technology

2 reports1 outlets20 days agoUpdate

The story so far

AI overview

Huawei Pharmaceutical's president Fan Jie clearly stated 'Huawei does not make drugs' and hopes to become the technical foundation for the AI pharmaceutical industry. Huawei provides pharmaceutical companies with computing power, storage, networking, tool chains, and data governance capabilities. Some collaborative projects have begun deploying computing clusters at the scale of hundreds of cards. Huawei possesses advantages in computing power, cluster capabilities, and the ecosystem, having collaborated with two medical enterprises to jointly build hundred-card clusters.

AI-written from the reports · Updated 20 days ago

Coverage timeline

Follow the coverage to see every side of the story.

30 Oct
  1. ITHome · AI
    Huawei Pharmaceutical Corps clearly does not produce drugs, positioning itself to empower pharmaceutical companies with AI.

    Fang Jie, CEO of Huawei Pharmaceutical Group, clearly stated that Huawei does not make drugs and hopes to become the technical foundation of AI pharmaceutical industry, providing computing power, storage, network, tool chain and data governance capabilities for pharmaceutical companies. Domestic wuxia game 'Xiang Zhi Ling Zero' debuts at the top of Steam global bestseller list, peak online player number reaches 430,000. Google's parent company Alphabet falls more than 13% in midday trading, creating its largest single-day decline in history, previously Q3 financial report shows revenue and net profit are not up to expectations, AI investment leads to negative free cash flow.

29 Oct
  1. ITHome · AI
    Huawei's Pharmaceutical Corps President Fan Jie clearly stated 'Huawei does not make drugs' and hopes to become the technical foundation of the AI pharmaceutical industry

    Huawei's Pharmaceutical Corps President Fan Jie clearly stated 'Huawei does not make drugs' and hopes to become the technical foundation of the AI pharmaceutical industry. Huawei provides pharmaceutical companies with computing power, storage, networking, tool chains, and data governance capabilities, and some collaborative projects have started deploying computing clusters at the scale of hundreds of cards. Huawei has the advantages of computing power, cluster capabilities, and an ecosystem, and has collaborated with two medical companies to jointly build a hundred-card cluster.